miR-451a, which in our study was also decreased significantly immediately post-RT, is an established regulator of cardiac fibrosis and inflammation via pathways related to angiotensin II and matrix metalloproteinases 2 and 9 (52, 53). The gene discussed is MMP2; the disease is fibrosis.